Found: 89
Select item for more details and to access through your institution.
A Pilot Trial Evaluating Zoledronic Acid Induced Changes in [<sup>18</sup>F]FMAU-Positron Emission Tomography Imaging of Bone Metastases in Prostate Cancer.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Surgical excision of duodenal/pancreatic metastatic renal cell carcinoma.
- Published in:
- Frontiers in Oncology, 2014, v. 4, p. 1, doi. 10.3389/fonc.2014.00218
- By:
- Publication type:
- Article
Predictive biomarkers for survival benefit with ramucirumab in urothelial cancer in the RANGE trial.
- Published in:
- Nature Communications, 2022, v. 13, n. 1, p. 1, doi. 10.1038/s41467-022-29441-y
- By:
- Publication type:
- Article
Infigratinib in Early-Line and Salvage Therapy for FGFR3-Altered Metastatic Urothelial Carcinoma.
- Published in:
- Clinical Genitourinary Cancer, 2022, v. 20, n. 1, p. 35, doi. 10.1016/j.clgc.2021.10.004
- By:
- Publication type:
- Article
A Prospective Multicenter Evaluation of Initial Treatment Choice in Metastatic Renal Cell Carcinoma Prior to the Immunotherapy Era: The MaRCC Registry Experience.
- Published in:
- Clinical Genitourinary Cancer, 2022, v. 20, n. 1, p. 1, doi. 10.1016/j.clgc.2021.07.002
- By:
- Publication type:
- Article
Treatment of Metastatic Urothelial Carcinoma After Previous Cisplatin-based Chemotherapy for Localized Disease: A Retrospective Comparison of Different Chemotherapy Regimens.
- Published in:
- Clinical Genitourinary Cancer, 2021, v. 19, n. 2, p. 125, doi. 10.1016/j.clgc.2020.10.006
- By:
- Publication type:
- Article
Safety and Efficacy of Sorafenib Therapy in Patients With Metastatic Kidney Cancer With Impaired Renal Function.
- Published in:
- Clinical Genitourinary Cancer, 2009, v. 7, n. 2, p. E10, doi. 10.3816/CGC.2009.n.015
- By:
- Publication type:
- Article
Current State of Systemic Therapies for Advanced Renal Cell Carcinoma.
- Published in:
- Current Oncology Reports, 2020, v. 22, n. 3, p. 1, doi. 10.1007/s11912-020-0892-1
- By:
- Publication type:
- Article
Cabozantinib as a Novel Therapy for Renal Cell Carcinoma.
- Published in:
- Current Oncology Reports, 2013, v. 15, n. 2, p. 76, doi. 10.1007/s11912-012-0289-x
- By:
- Publication type:
- Article
Predictive biomarkers for survival benefit with ramucirumab in urothelial cancer in the RANGE trial.
- Published in:
- Nature Communications, 2022, v. 13, n. 1, p. 1, doi. 10.1038/s41467-022-29441-y
- By:
- Publication type:
- Article
Phase 1 study to evaluate the effects of rifampin on pharmacokinetics of pevonedistat, a NEDD8-activating enzyme inhibitor in patients with advanced solid tumors.
- Published in:
- Investigational New Drugs, 2022, v. 40, n. 5, p. 1042, doi. 10.1007/s10637-022-01286-8
- By:
- Publication type:
- Article
A phase 1 study to assess the safety, pharmacokinetics, and anti-tumor activity of the androgen receptor n-terminal domain inhibitor epi-506 in patients with metastatic castration-resistant prostate cancer.
- Published in:
- Investigational New Drugs, 2022, v. 40, n. 2, p. 322, doi. 10.1007/s10637-021-01202-6
- By:
- Publication type:
- Article
Phase Ia dose escalation study of OBP-801, a cyclic depsipeptide class I histone deacetylase inhibitor, in patients with advanced solid tumors.
- Published in:
- Investigational New Drugs, 2022, v. 40, n. 2, p. 300, doi. 10.1007/s10637-021-01180-9
- By:
- Publication type:
- Article
Phase I study combining the aurora kinase a inhibitor alisertib with mFOLFOX in gastrointestinal cancer.
- Published in:
- Investigational New Drugs, 2019, v. 37, n. 2, p. 315, doi. 10.1007/s10637-018-0663-0
- By:
- Publication type:
- Article
Correction to: Phase I study combining the aurora kinase a inhibitor alisertib with mFOLFOX in gastrointestinal cancer.
- Published in:
- Investigational New Drugs, 2018, v. 36, n. 6, p. 1158, doi. 10.1007/s10637-018-0679-5
- By:
- Publication type:
- Article
First-in-human trial of an anti-5T4 antibody-monomethylauristatin conjugate, PF-06263507, in patients with advanced solid tumors.
- Published in:
- Investigational New Drugs, 2017, v. 35, n. 3, p. 315, doi. 10.1007/s10637-016-0419-7
- By:
- Publication type:
- Article
A phase II trial of ganetespib, a heat shock protein 90 Hsp90) inhibitor, in patients with docetaxel-pretreated metastatic castrate-resistant prostate cancer (CRPC)-a prostate cancer clinical trials consortium (PCCTC) study.
- Published in:
- Investigational New Drugs, 2016, v. 34, n. 1, p. 112, doi. 10.1007/s10637-015-0307-6
- By:
- Publication type:
- Article
Pharmacokinetics of carfilzomib in patients with advanced malignancies and varying degrees of hepatic impairment: an open-label, single-arm, phase 1 study.
- Published in:
- Experimental Hematology & Oncology, 2017, v. 6, p. 1, doi. 10.1186/s40164-017-0086-1
- By:
- Publication type:
- Article
Adjuvant Chemo-/Hormonal Therapy Trials for Locally Advanced Prostate Cancer.
- Published in:
- Current Oncology Reports, 2000, v. 2, n. 5, p. 402, doi. 10.1007/s11912-000-0059-z
- By:
- Publication type:
- Article
Experts Discuss Treatment Methodologies in RCC.
- Published in:
- Oncology (08909091), 2023, v. 37, n. 1, p. 36
- By:
- Publication type:
- Article
An HER2 DNA vaccine with evolution-selected amino acid substitutions reveals a fundamental principle for cancer vaccine formulation in HER2 transgenic mice.
- Published in:
- Cancer Immunology, Immunotherapy, 2019, v. 68, n. 7, p. 1143, doi. 10.1007/s00262-019-02333-9
- By:
- Publication type:
- Article
The effect of sonidegib (LDE225) on the pharmacokinetics of bupropion and warfarin in patients with advanced solid tumours.
- Published in:
- British Journal of Clinical Pharmacology, 2021, v. 87, n. 3, p. 1291, doi. 10.1111/bcp.14508
- By:
- Publication type:
- Article
A phase I pharmacokinetic study of belinostat in patients with advanced cancers and varying degrees of liver dysfunction.
- Published in:
- British Journal of Clinical Pharmacology, 2019, v. 85, n. 11, p. 2499, doi. 10.1111/bcp.14054
- By:
- Publication type:
- Article
Novel Approaches with HIF-2α Targeted Therapies in Metastatic Renal Cell Carcinoma.
- Published in:
- Cancers, 2024, v. 16, n. 3, p. 601, doi. 10.3390/cancers16030601
- By:
- Publication type:
- Article
Analysis of the Tumor Immune Microenvironment (TIME) in Clear Cell Renal Cell Carcinoma (ccRCC) Reveals an M0 Macrophage-Enriched Subtype: An Exploration of Prognostic and Biological Characteristics of This Immune Phenotype.
- Published in:
- Cancers, 2023, v. 15, n. 23, p. 5530, doi. 10.3390/cancers15235530
- By:
- Publication type:
- Article
Immunotherapy and Immune Evasion in Prostate Cancer.
- Published in:
- Cancers, 2013, v. 5, n. 2, p. 569, doi. 10.3390/cancers5020569
- By:
- Publication type:
- Article
Perioperative Approaches to Kidney Cancer.
- Published in:
- Clinical Advances in Hematology & Oncology, 2020, v. 18, n. 1, p. 56
- By:
- Publication type:
- Article
Lessons from 801 clinical TFE3/TFEB fluorescence in situ hybridization assays performed on renal cell carcinoma suspicious for MiTF family aberrations.
- Published in:
- American Journal of Clinical Pathology, 2023, v. 160, n. 6, p. 549, doi. 10.1093/ajcp/aqad089
- By:
- Publication type:
- Article
Cediranib in combination with various anticancer regimens: results of a phase I multi-cohort study.
- Published in:
- Investigational New Drugs, 2011, v. 29, n. 6, p. 1395, doi. 10.1007/s10637-010-9484-5
- By:
- Publication type:
- Article
A Phase II study of celecoxib, gemcitabine, and cisplatin in advanced pancreatic cancer.
- Published in:
- Investigational New Drugs, 2005, v. 23, n. 6, p. 583, doi. 10.1007/s10637-005-1028-z
- By:
- Publication type:
- Article
Phase II trial of fenretinide in advanced renal carcinoma.
- Published in:
- Investigational New Drugs, 2005, v. 23, n. 2, p. 179, doi. 10.1007/s10637-005-5864-7
- By:
- Publication type:
- Article
Longitudinal Analysis of a Model to Predict Quality of Life in Prostate Cancer Patients and their Spouses.
- Published in:
- Annals of Behavioral Medicine, 2008, v. 36, n. 2, p. 117, doi. 10.1007/s12160-008-9058-3
- By:
- Publication type:
- Article
A phase Ib study evaluating the recommended phase II dose, safety, tolerability, and efficacy of mivavotinib in combination with nivolumab in advanced solid tumors.
- Published in:
- Cancer Medicine, 2024, v. 13, n. 5, p. 1, doi. 10.1002/cam4.6776
- By:
- Publication type:
- Article
Cabozantinib real‐world effectiveness in the first‐through fourth‐line settings for the treatment of metastatic renal cell carcinoma: Results from the International Metastatic Renal Cell Carcinoma Database Consortium.
- Published in:
- Cancer Medicine, 2021, v. 10, n. 4, p. 1212, doi. 10.1002/cam4.3717
- By:
- Publication type:
- Article
Characterizing the outcomes of metastatic papillary renal cell carcinoma.
- Published in:
- Cancer Medicine, 2017, v. 6, n. 5, p. 902, doi. 10.1002/cam4.1048
- By:
- Publication type:
- Article
Venous thromboembolism in metastatic urothelial carcinoma or variant histologies: incidence, associative factors, and effect on survival.
- Published in:
- Cancer Medicine, 2017, v. 6, n. 1, p. 186, doi. 10.1002/cam4.986
- By:
- Publication type:
- Article
Phase I Study of Anti-CD3 x Anti-Her2 Bispecific Antibody in Metastatic Castrate Resistant Prostate Cancer Patients.
- Published in:
- Prostate Cancer (20903111), 2015, v. 2015, p. 1, doi. 10.1155/2015/285193
- By:
- Publication type:
- Article
Evolving Treatment Paradigms in Non-clear Cell Kidney Cancer.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Cabozantinib for Renal Cell Carcinoma: Current and Future Paradigms.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Systemic therapy of advanced urothelial cancer.
- Published in:
- 2009
- By:
- Publication type:
- journal article
Phase II trial of carboplatin and paclitaxel in cisplatin‐pretreated advanced transitional cell carcinoma: A Southwest Oncology Group studyAddress for reprints: Southwest Oncology Group (SWOG‐9457), Operations Office, 14980 Omicron Dr., San Antonio, TX 78245‐3217; Fax: (210) 677‐0006; E‐mail: pubs@swog.org
- Published in:
- Cancer (0008543X), 2005, v. 104, n. 8, p. 1627
- By:
- Publication type:
- Article
Phase II evaluation of paclitaxel, α-interferon, and cis-retinoic acid in advanced renal cell carcinoma.
- Published in:
- Cancer (0008543X), 2001, v. 92, n. 3, p. 519, doi. 10.1002/1097-0142(20010801)92:3<519::AID-CNCR1350>3.0.CO;2-#
- By:
- Publication type:
- Article
Imaging DNA synthesis with [<sup>18</sup>F]FMAU and positron emission tomography in patients with cancer.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2005, v. 32, n. 1, p. 15, doi. 10.1007/s00259-004-1713-8
- By:
- Publication type:
- Article
Phase-II study of dose attenuated schedule of irinotecan, capecitabine, and celecoxib in advanced colorectal cancer.
- Published in:
- 2008
- By:
- Publication type:
- journal article
Phase-II study of dose attenuated schedule of irinotecan, capecitabine, and celecoxib in advanced colorectal cancer.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2008, v. 61, n. 2, p. 283, doi. 10.1007/s00280-007-0472-1
- By:
- Publication type:
- Article
Adjuvant Everolimus in Non–Clear Cell Renal Cell Carcinoma: A Secondary Analysis of a Randomized Clinical Trial.
- Published in:
- JAMA Network Open, 2024, v. 7, n. 8, p. e2425288, doi. 10.1001/jamanetworkopen.2024.25288
- By:
- Publication type:
- Article
Percutaneous cryoablation of adrenal metastases: technical feasibility and safety.
- Published in:
- Abdominal Radiology, 2021, v. 46, n. 6, p. 2805, doi. 10.1007/s00261-020-02848-1
- By:
- Publication type:
- Article
Management and outcomes of patients with renal medullary carcinoma: a multicentre collaborative study.
- Published in:
- BJU International, 2017, v. 120, n. 6, p. 782, doi. 10.1111/bju.13705
- By:
- Publication type:
- Article
Neoadjuvant vs. Adjuvant Chemotherapy in Muscle Invasive Bladder Cancer (MIBC): Analysis From the RISC Database.
- Published in:
- Frontiers in Oncology, 2018, p. N.PAG, doi. 10.3389/fonc.2018.00463
- By:
- Publication type:
- Article
Correction to: A Phase 1B open-label study of gedatolisib (PF-05212384) in combination with other anti-tumour agents for patients with advanced solid tumours and triple-negative breast cancer.
- Published in:
- 2023
- By:
- Publication type:
- Correction Notice